Product Code: GVR-3-68038-839-8
The global agricultural biotechnology market size is expected to reach USD 161.45 billion by 2025 growing at a CAGR of 7.07%, according to a new report by Grand View Research, Inc. Advent of unique genetic resources and genome modification tools is anticipated to enhance understanding of plant biology over the coming years. Additionally, a rise in demand for biofuel owing to depletion of conventional fuel is further projected to propel the market growth.
Penetration of genetic engineering tools has been recognized as a solution to overcome the pitfalls of conventional vaccine production. Genetically engineered vaccines have the potential of transforming the vaccine development scenario in the future. These products are continuously assessed by vaccine developing companies to understand the significance of recombinant vaccines in clinical as well as economical aspects which has made significant contributions to the revenue generated by vaccine development application segment in 2018.
Development of transgenic livestock is expected to immensely impact the improvement of nutrition, human health, animal welfare, reducing diseased livestock, and enhancing environmental protection. Moreover, genetic modification carried out in stem cells, livestock, and others are attributed to result in high-quality food and more yield from livestock. Some of the frequently adopted techniques for the development of transgenic animals include recombinant retroviruses, pronuclear Injection, sperm-mediated DNA transfer, embryonic stem cells, germ cell transplantation, and nuclear transfer "Cloning".
Further key findings from the study suggest:
- Transgenic crops & animals segment accounted for the highest revenue generated in 2018 and is anticipated to maintain this trend throughout the forecast period
- Vaccine development segment is set to grow at the fastest pace from 2019-2025
- Agricultural biotechnology for plants has dominated with respect to market share and is projected to maintain its dominance throughout the forecast period
- Agricultural biotechnology for animals is the fastest growing organism type segment from 2019-2025
- North America is the leading regional market due to the high penetration of novel biotechnology tools
- In addition, a number of public-private partnerships has grown significantly in this region. These initiatives allow the development and maintenance of public infrastructure, agriculture, and healthcare programs in North America
- Asia Pacific is projected to be the fastest-growing regional market owing to supportive climatic conditions in different countries, which allows multiple growing seasons in a single year
- A robust network of local agricultural biotechnology manufacturers has significantly contributed to the revenue generated by Asia Pacific
Some of the key participants in agricultural biotechnology market are: KWS SAAT SE & Co. KGaA, Corteva, MITSUI & CO., LTD, Evogene Ltd., Valent BioSciences LLC, and Bayer AG among others
Table of Contents
Chapter 1 Executive Summary
Chapter 2 Research Methodology
- 2.1 Information Procurement
- 2.2 Information or Data Analysis
- 2.3 Market Formulation & Validation
Chapter 3 Agricultural Biotechnology Market Variables, Trends & Scope
- 3.1 Market Segmentation & Scope
- 3.1.1 Market driver analysis
- 3.1.1.1 Growth in adoption of genetically modified/biotech crops
- 3.1.1.2 Increase in biotech crop area
- 3.1.1.3 Technological advancements
- 3.1.2 Market restraint analysis
- 3.1.2.1 Lengthy development process
- 3.1.2.2 Risks pertaining to the usage of genetically modified food
- 3.2 Penetration & Growth Prospect Mapping for Application, 2018
- 3.3 Global Agricultural Biotechnology Market-Swot Analysis, By Factor (Political & Legal, Economic, and Technological)
- 3.4 Industry Analysis - Porter's
Chapter 4 Agricultural Biotechnology Market Categorization: Application Estimates & Trend Analysis
- 4.1 Agricultural Biotechnology Market: Application Movement Analysis
- 4.2 Vaccine Development
- 4.2.1 Agricultural biotechnology market for vaccine development, 2014 - 2025 (USD Billion)
- 4.3 Transgenic Crops & Animals
- 4.3.1 Agricultural biotechnology market for transgenic crops & animals, 2014 - 2025 (USD Billion)
- 4.4 Antibiotic Development
- 4.4.1 Agricultural biotechnology market for antibiotic development, 2014 - 2025 (USD Billion)
- 4.5 Nutritional Supplements
- 4.5.1 Agricultural biotechnology market for nutritional supplements, 2014 - 2025 (USD Billion)
- 4.6 Flower Culturing
- 4.6.1 Agricultural biotechnology market for flower culturing, 2014 - 2025 (USD Billion)
- 4.7 Biofuels
- 4.7.1 Agricultural biotechnology market for biofuels, 2014 - 2025 (USD Billion)
Chapter 5 Agricultural Biotechnology Market Categorization: Organism Estimates & Trend Analysis
- 5.1 Agricultural Biotechnology Market: Organism Movement Analysis
- 5.2 Plants
- 5.2.1 Plant-based agricultural biotechnology market, 2014 - 2025 (USD Billion)
- 5.2.2 Conventional techniques
- 5.2.2.1 Plant-based agricultural biotechnology market for conventional techniques, 2014 - 2025 (USD Billion)
- 5.2.3 Established Techniques Of Genetic Modification (ETGM)
- 5.2.3.1 Plant-based agricultural biotechnology market for ETGM, 2014 - 2025 (USD Billion)
- 5.2.4 New Breeding Techniques (NBT)
- 5.2.4.1 Plant-based agricultural biotechnology market for NBT, 2014 - 2025 (USD Billion)
- 5.3 Comparative Analysis: New Breeding Techniques Vs Conventional Breeding Techniques
- 5.4 Animals
- 5.4.1 Animal-based agricultural biotechnology market, 2014 - 2025 (USD Billion)
- 5.4.2 Conventional techniques
- 5.4.2.1 Animal-based agricultural biotechnology market for conventional techniques, 2014 - 2025 (USD Billion)
- 5.4.3 Established Techniques of Genetic Modification (ETGM)
- 5.4.3.1 Animal-based agricultural biotechnology market for ETGM, 2014 - 2025 (USD Billion)
- 5.4.4 New Breeding Techniques (NBT)
- 5.4.4.1 Animal-based agricultural biotechnology market for NBT, 2014 - 2025 (USD Billion)
- 5.5 Microbes
- 5.5.1 Microbe-based agricultural biotechnology market, 2014 - 2025 (USD Billion)
- 5.5.2 Conventional techniques
- 5.5.2.1 Microbe-based agricultural biotechnology market for conventional techniques, 2014 - 2025 (USD Billion)
- 5.5.3 Established Techniques of Genetic Modification (ETGM)
- 5.5.3.1 Microbe-based agricultural biotechnology market for ETGM, 2014 - 2025 (USD Billion)
- 5.5.4 New Breeding Techniques (NBT)
- 5.5.4.1 Microbe-based agricultural biotechnology market for NBT, 2014 - 2025 (USD Billion)
Chapter 6 Agricultural Biotechnology Market Categorization: Regional Estimates & Trend Analysis by Application and Organism
- 6.1 North America
- 6.1.1 North America agricultural biotechnology market, 2014 - 2025 (USD Billion)
- 6.1.2 U.S.
- 6.1.2.1 U.S. agricultural biotechnology market, 2014 - 2025 (USD Billion)
- 6.1.3 Canada
- 6.1.3.1 Canada agricultural biotechnology market, 2014 - 2025 (USD Billion)
- 6.2 Europe
- 6.2.1 Europe agricultural biotechnology market, 2014 - 2025 (USD Billion)
- 6.2.2 UK
- 6.2.2.1 UK agricultural biotechnology market, 2014 - 2025 (USD Billion)
- 6.2.3 Germany
- 6.2.3.1 Germany agricultural biotechnology market, 2014 - 2025 (USD Billion)
- 6.3 Asia Pacific
- 6.3.1 Asia Pacific agricultural biotechnology market, 2014 - 2025 (USD Billion)
- 6.3.2 Japan
- 6.3.2.1 Japan agricultural biotechnology market, 2014 - 2025 (USD Billion)
- 6.3.3 China
- 6.3.3.1 China agricultural biotechnology market, 2014 - 2025 (USD Billion)
- 6.4 Latin America
- 6.4.1 Latin America agricultural biotechnology market, 2014 - 2025 (USD Billion)
- 6.4.2 Brazil
- 6.4.2.1 Brazil agricultural biotechnology market, 2014 - 2025 (USD Billion)
- 6.5 Middle East & Africa
- 6.5.1 Middle East & Africa agricultural biotechnology market, 2014 - 2025 (USD Billion)
- 6.5.2 South Africa
- 6.5.2.1 South Africa agricultural biotechnology market, 2014 - 2025 (USD Billion)
Chapter 7 Competitive Landscape
- 7.1 Strategy Framework
- 7.2 Market Participation Categorization
- 7.3 Company Profiles
- 7.3.1 KWS SAAT SE & Co. KGaA
- 7.3.1.1 Company overview
- 7.3.1.2 Financial performance
- 7.3.1.3 Product benchmarking
- 7.3.1.4 Strategic initiatives
- 7.3.2 ChemChina
- 7.3.2.1 Company overview
- 7.3.2.2 Syngenta
- 7.3.2.2.1 Company overview
- 7.3.2.3 Financial performance
- 7.3.2.4 Product benchmarking
- 7.3.2.5 Strategic initiatives
- 7.3.3 Corteva
- 7.3.3.1 Company overview
- 7.3.3.2 Product benchmarking
- 7.3.3.3 Strategic initiatives
- 7.3.4 Limagrain
- 7.3.4.1 Company overview
- 7.3.4.2 VILMORIN & CIE
- 7.3.4.2.1 Company overview
- 7.3.4.3 Financial performance
- 7.3.4.4 Product benchmarking
- 7.3.4.5 Strategic initiatives
- 7.3.5 MITSUI & CO., LTD.
- 7.3.5.1 Company overview
- 7.3.5.2 Certis USA
- 7.3.5.2.1 Company overview
- 7.3.5.3 Financial performance
- 7.3.5.4 Product benchmarking
- 7.3.5.5 Strategic initiatives
- 7.3.6 Evogene Ltd.
- 7.3.6.1 Company overview
- 7.3.6.2 Financial performance
- 7.3.6.3 Product benchmarking
- 7.3.6.4 Strategic initiatives
- 7.3.7 Bayer AG
- 7.3.7.1 Company overview
- 7.3.7.2 Monsanto Company
- 7.3.7.2.1 Company overview
- 7.3.7.3 Financial performance
- 7.3.7.4 Product benchmarking
- 7.3.7.5 Strategic initiatives
- 7.3.8 Valent BioSciences LLC
- 7.3.8.1 Company overview
- 7.3.8.2 Product benchmarking
- 7.3.8.3 Strategic initiatives
- 7.3.9 Nufarm
- 7.3.9.1 Company overview
- 7.3.9.2 Financial performance
- 7.3.9.3 Product benchmarking
- 7.3.9.4 Strategic initiatives
- 7.3.10 Marrone Bio Innovations
- 7.3.10.1 Company overview
- 7.3.10.2 Financial performance
- 7.3.10.3 Product benchmarking
- 7.3.10.4 Strategic initiatives
- 7.3.11 Performance Plants Inc.
- 7.3.11.1 Company overview
- 7.3.11.2 Product benchmarking
- 7.3.11.3 Strategic initiatives
- 7.3.12 ADAMA Ltd
- 7.3.12.1 Company overview
- 7.3.12.2 Financial performance
- 7.3.12.3 Product benchmarking
- 7.3.12.4 Strategic initiatives